Relmada Therapeutics, Inc. RLMD
Set alert
3.58 USD +0.14 +4.07%
At close · Oct 30
3.50 -0.08 -2.23%
After hours · Oct 30, 4:13 PM ET
3.31 Day range 3.66
2.20 52-week range 7.86
- YTD
- -25.88%
- 1 year
- +54.31%
- Open
- 3.42
- Prev close
- 3.44
- Mkt cap
- 381.88M
- Vol
- 1.41M
- Avg vol
- 1.33M
- EPS
- -0.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.31
- High
- 3.66
- Forward P/E
- -0.19
- Beta
- 0.41
- Short ratio
- 4.52
- Inst. own
- 46.06%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 3.33
- 1y target
- 0.86667
Ownership
Held by insiders 8.04%
Held by institutions 46.06%
Float held by institutions 50.09%
Institutions 92
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin Resources, Inc. | 13.16% | 1,302,151 | 494.30K | Sep 29, 2024 |
| Vanguard Group Inc | 12.70% | 1,256,705 | 477.05K | Sep 29, 2024 |
| Acadian Asset Management. LLC | 11.99% | 1,186,452 | 450.38K | Sep 29, 2024 |
| Parsons Capital Management, Inc. | 10.13% | 1,002,695 | 380.62K | Sep 29, 2024 |
| Palo Alto Investors Lp | 7.40% | 732,400 | 278.02K | Sep 29, 2024 |
| Deep Track Capital, Lp | 6.82% | 674,833 | 256.17K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 8.61% | 851,916 | 323.39K | Sep 29, 2024 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 3.78% | 374,029 | 141.98K | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 3.57% | 353,625 | 134.24K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 1.59% | 157,021 | 59.60K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 1.01% | 100,177 | 38.03K | Sep 29, 2024 |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 0.94% | 93,077 | 35.33K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CASAMENTO CHARLES J | Director | Stock Gift | Oct 21, 2024 | 0 |
| ENCE CHARLES | Officer | Purchase | Jan 30, 2024 | 38,970 |
| KELLY PAUL EDWARD | Director | Purchase | Sep 8, 2024 | 212,295 |
| O'GORMAN CEDRIC | Officer | Purchase | May 22, 2023 | 10,121 |
| SHENOUDA MAGED R | Chief Financial Officer | Purchase | Sep 10, 2024 | 88,335 |
| TRAVERSA SERGIO | Chief Executive Officer | Purchase | Sep 10, 2024 | 384,024 |
Held by funds
55 US ETFs and mutual funds hold RLMD · largest positions